De novo expression of fetal ED-A+ fibronectin and B+ tenascin-C splicing variants in human cardiac allografts: potential impact for targeted therapy of rejection
Crossref DOI link: https://doi.org/10.1007/s10735-014-9573-4
Published Online: 2014-05-03
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Franz, Marcus
Matusiak-Brückner, Monika
Richter, Petra
Grün, Katja
Ziffels, Barbara
Neri, Dario
Maschek, Hansjörg
Schulz, Uwe
Pfeil, Alexander
Jung, Christian
Figulla, Hans R.
Gummert, Jan
Berndt, Alexander
Renner, André
Text and Data Mining valid from 2014-05-03